LAG3 and neoplasm: In contrast, the simultaneous inhibition of LAG-3 and PD-1 receptors had a synergistic effect, leading to a reduction in tumor growth and the enhancement of anti-tumor immune responses, which may be attributable to differences in the inhibitory mechanisms and or expression patterns of PD-1 and LAG-3 (129).